Thyroid fine-needle aspiration: the relevance of BRAF mutation testing

Endocrine

Volumn 47, Issue 2, 2014, Pages 351-353

  Di Benedetto, Giuseppe ^a  

^a Hospital of Aversa   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; TUMOR MARKER; BRAF PROTEIN, HUMAN;

ASPIRATION CYTOLOGY; BRAF GENE; CANCER DIAGNOSIS; CANCER PROGNOSIS; CLINICAL FEATURE; DNA EXTRACTION; ECHOGRAPHY; EDITORIAL; FINE NEEDLE ASPIRATION BIOPSY; GENE MUTATION; HUMAN; MUTATIONAL ANALYSIS; THYROID FINE NEEDLE ASPIRATION BIOPSY; THYROID NODULE; THYROID PAPILLARY CARCINOMA; FEMALE; GENETICS; MALE; NUCLEOTIDE SEQUENCE; PATHOLOGY; THYROID TUMOR;

DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; MALE; PROTO-ONCOGENE PROTEINS B-RAF; THYROID NEOPLASMS; THYROID NODULE;

EID: 84911003312     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-014-0222-1     Document Type: Editorial

References (11)

1. J.Y. Seo, E.-K. Kim, J.Y. Kwak, Additional BRAF mutation analysis may have additional diagnostic value in thyroid nodules with “suspicious for malignant” cytology alone even when the nodules do not show suspicious US features. Endocrine (2014). doi:10.1007/s12020-013-0150-5
2. R. Elisei, D. Viola, L. Torregrossa, R. Giannini, C. Romei, C. Ugolini, E. Molinaro, L. Agate, A. Biagini, C. Lupi, L. Valerio, G. Materazzi, P. Miccoli, P. Piaggi, A. Pinchera, P. Vitti, F. Basolo, The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study. J. Clin. Endocrinol. Metab. 97, 4390–4398 (2012)
3. S.H. Jeong, H.S. Hong, E.H. Lee, J.G. Cha, J.S. Park, J.J. Kwak, Outcome of Thyroid Nodules Characterized as Atypia of Undetermined Significance or Follicular Lesion of Undetermined Significance and Correlation With Ultrasound Features and BRAF(V600E) Mutation Analysis. AJR Am. J. Roentgenol. 201, 854–860 (2013)
4. D. Barbaro, R.M. Incensati, G. Materazzi, G. Boni, M. Grosso, E. Panicucci, P. Lapi, C. Pasquini, P. Miccoli, The BRAF V600E mutation in papillary thyroid cancer with positive or suspected pre-surgical cytological finding is not associated with advanced stages or worse prognosis. Endocrine (2013). doi:10.1007/s12020-013-0029-5
5. T.H. Kim, Y.J. Park, J.A. Lim, H.Y. Ahn, E.K. Lee, Y.J. Lee, K.W. Kim, S.K. Hahn, Y.K. Youn, K.H. Kim, B.Y. Cho, J. Park do, The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis. Cancer 118(7), 1764–1773 (2012)
6. G. Di Benedetto, A. Fabozzi, C. Rinaldi, Clinical management of thyroid nodules with indeterminate cytology: our institutional experience using SIAPEC cytological criteria and V600-BRAF test. Pathologica 105(1), 1–4 (2013)
7. J.K. Nam, C.K. Jung, B.J. Song, D.J. Lim, B.J. Chae, N.S. Lee, W.C. Park, J.S. Kim, S.S. Jung, J.S. Bae, Is the BRAF(V600E) mutation useful as a predictor of preoperative risk in papillary thyroid cancer? Am. J. Surg. 203(4), 436–441 (2012)
8. J.P. Lopes, E. Fonseca, BRAF gene mutation in the natural history of papillary thyroid carcinoma:diagnostic and prognostic implications. Acta. Med. Port. 24(Suppl 4), 855–868 (2011)
9. W.J. Moon, N. Choi, J.W. Choi, S.K. Kim, T.S. Hwang, BRAF mutation analysis and sonography as adjuncts to fine-needle aspiration cytology of papillary thyroid carcinoma: their relationships and roles. AJR Am. J. Roentgenol. 198(3), 668–674 (2012)
10. E. Puxeddu, S. Filetti, BRAF mutation assessment in papillary thyroid cancer: are we ready to use it in clinical practice? Endocrine (2013). doi:10.1007/s12020-013-0139-0
11. G. Di Benedetto, A. Fabozzi, C. Rinaldi, C.R. Rinaldi, BRAF test and cytological diagnosis with a single fine needle cytology sample. Acta. Cytol. 57(4), 337–340 (2013)